×

Business / Stock Market

Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug

Published May 04 2021 at 10:05 AM GMT

The Motley Fool @fool.com

Add to Collections
Report Post

Continue reading at fool.com

Key
Points

The drugmaker is also looking for its highest sales ever in 2021 in large part because of remdesivir.

Credit

Tags

Continue reading at fool.com

Posted in Business, Stock Market

Stats

Published May 4, 2021 10:05 AM GMT